CSTL Q1 2021 Earnings — Castle Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CSTLCastle Biosciences, Inc.

$805M

Q1 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$23M+31.0% YoY

Gross Profit

$20M86.7% margin

Operating Income

-$4M-18.8% margin

Net Income

-$4M-18.8% margin

EPS (Diluted)

$-0.17

QoQ Revenue Growth

+31.9%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$437M

Total Liabilities

$19M

Stockholders' Equity

$419M

Cash & Equivalents

$407M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$23M	$17M	+31.0%
Gross Profit	$20M	$15M	+31.7%
Operating Income	-$4M	$1M	-513.5%
Net Income	-$4M	$570,000	-850.9%